Literature DB >> 20016992

Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa.

Hiroto Miwa1, Junichi Koseki, Tadayuki Oshima, Takashi Kondo, Toshihiko Tomita, Jiro Watari, Takayuki Matsumoto, Tomohisa Hattori, Kunitsugu Kubota, Seiichi Iizuka.   

Abstract

BACKGROUND: A traditional Japanese medicine, rikkunshito, has been reported to relieve dyspepsia symptoms. We investigated the effect of rikkunshito on RE-induced abdominal dyspepsia, and performed experiments to elucidate the mechanism of that effect.
METHODS: RE model rats were prepared using 8-week-old male Wistar rats, and rikkunshito was administered in drinking water. Voluntary movement was used as an index of RE-induced abdominal dyspepsia, which was monitored by an infrared sensor. On the tenth day after surgery, the total area of esophageal erosion was measured, and samples of nonerosive mucosa were collected. Using those samples, intercellular spaces of epithelial mucosa were examined by transmission electron microscopy, and the NP-40-soluble and -insoluble levels of the tight junction proteins claudin-1, -3 and -4 and their mRNAs were determined.
RESULTS: Rikkunshito did not reduce the average total area of erosive lesions in the esophageal mucosa of RE model rats. On day 10, voluntary movement was significantly decreased in the RE model rats and rikkunshito significantly increased it. Nonerosive esophageal mucosa from RE rats showed dilation of intercellular spaces in epithelium, and significantly decreased claudin-3 mRNA and protein levels. Rikkunshito significantly suppressed intercellular space dilation and significantly increased the level of NP-40-insoluble claudin-3, but it did not affect the mRNA level, suggesting that it promoted tight junction formation by facilitating the translocation of proteins.
CONCLUSION: Rikkunshito increased voluntary movement in RE model rats. This may have been because rikkunshito ameliorated the symptoms of RE by improving the barrier function of esophageal mucosa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016992     DOI: 10.1007/s00535-009-0180-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

1.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

Review 2.  Japanese herbal medicine in functional gastrointestinal disorders.

Authors:  H Suzuki; J M Inadomi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2009-03-25       Impact factor: 3.598

3.  Changes of the neuropeptides content and gene expression in spinal cord and dorsal root ganglion after noxious colorectal distension.

Authors:  Ching-Liang Lu; Pankaj J Pasricha; Jen-Chuen Hsieh; Ray-Hwa Lu; Chun-Ru Lai; Learn-Long Wu; Full-Young Chang; Shou-Dong Lee
Journal:  Regul Pept       Date:  2005-11

4.  Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

Authors:  E Dimenäs; G Carlsson; H Glise; B Israelsson; I Wiklund
Journal:  Scand J Gastroenterol Suppl       Date:  1996

5.  Possible involvement of phosphorylation of occludin in tight junction formation.

Authors:  A Sakakibara; M Furuse; M Saitou; Y Ando-Akatsuka; S Tsukita
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

6.  Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

Authors:  E Dimenäs
Journal:  Scand J Gastroenterol Suppl       Date:  1993

7.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

8.  Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.

Authors:  H Miwa; M Sasaki; T Furuta; T Koike; Y Habu; M Ito; Y Fujiwara; T Wada; A Nagahara; M Hongo; T Chiba; Y Kinoshita
Journal:  Aliment Pharmacol Ther       Date:  2007-07-01       Impact factor: 8.171

9.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.

Authors:  Mikio Furuse; Masaki Hata; Kyoko Furuse; Yoko Yoshida; Akinori Haratake; Yoshinobu Sugitani; Tetsuo Noda; Akiharu Kubo; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2002-03-11       Impact factor: 10.539

10.  Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

Authors:  Takakazu Oka; Yoko Tamagawa; Sota Hayashida; Yuko Kaneda; Naoki Kodama; Sadatoshi Tsuji
Journal:  Biopsychosoc Med       Date:  2007-11-15
View more
  22 in total

1.  Rikkunshito improves globus sensation in patients with proton-pump inhibitor-refractory laryngopharyngeal reflux.

Authors:  Ryoji Tokashiki; Isaku Okamoto; Nobutoshi Funato; Mamoru Suzuki
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

2.  Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis.

Authors:  Jing Shan; Tadayuki Oshima; Taichiro Muto; Koubun Yasuda; Hirokazu Fukui; Jiro Watari; Kenji Nakanishi; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2014-08-17       Impact factor: 7.527

3.  Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats.

Authors:  Takahiro Masuda; Fumiaki Yano; Nobuo Omura; Kazuto Tsuboi; Masato Hoshino; Se Ryung Yamamoto; Shunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2017-11-15       Impact factor: 3.199

4.  Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy.

Authors:  Shuji Takiguchi; Yuichiro Hiura; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Hiroshi Hosoda; Kenji Kangawa; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2012-08-16       Impact factor: 7.370

5.  Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease.

Authors:  Miwa Nahata; Shuichi Muto; Nobuhiko Oridate; Shunsuke Ohnishi; Koji Nakagawa; Chiharu Sadakane; Yayoi Saegusa; Tomohisa Hattori; Masahiro Asaka; Hiroshi Takeda
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

Review 6.  Sorting out the Relationship between Gastroesophageal Reflux Disease and Sleep.

Authors:  Michael Kurin; Fahmi Shibli; Yoshitaka Kitayama; Yeseong Kim; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

7.  A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Authors:  Kazunari Tominaga; Mototsugu Kato; Hiroshi Takeda; Yasuyuki Shimoyama; Eiji Umegaki; Ryuichi Iwakiri; Kenji Furuta; Koichi Sakurai; Takeo Odaka; Hiroaki Kusunoki; Akihito Nagahara; Katsuhiko Iwakiri; Takahisa Furuta; Kazunari Murakami; Hiroto Miwa; Yoshikazu Kinoshita; Ken Haruma; Shin'ichi Takahashi; Sumio Watanabe; Kazuhide Higuchi; Motoyasu Kusano; Kazuma Fujimoto; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2014-02-18       Impact factor: 7.527

Review 8.  Gastrointestinal mucosal barrier function and diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-04-05       Impact factor: 7.527

9.  Changes in ghrelin-related factors in gastroesophageal reflux disease in rats.

Authors:  Miwa Nahata; Yayoi Saegusa; Yumi Harada; Naoko Tsuchiya; Tomohisa Hattori; Hiroshi Takeda
Journal:  Gastroenterol Res Pract       Date:  2013-04-04       Impact factor: 2.260

Review 10.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.